Micell Receives $15 Million Equity Investment
RALEIGH, NC, September 21, 2009 ‐ Micell Technologies announced today that St. Jude Medical, Inc. has made a $15 million equity investment in the company.
Arthur J. Benvenuto, chairman and chief executive officer of Micell, said, “We are excited to have a company of St. Jude Medical’s stature make an investment in Micell. We look forward to collaborating with them to expand the use of our coating technology into potentially new applications for medical device products.”
About Micell Technologies Inc. ‐ Micell Technologies is a privately‐held, development‐stage biomedical company dedicated to developing innovative interventional cardiology systems. To learn more, please visit our Web site at www.www.micell.com.
Contact: Micell Technologies
Arthur J. Benvenuto, Chairman & CEO